纳武利尤单抗致中毒性表皮坏死松解症1例

doi:10.3969/j.issn.2095-1264.2024.06.18

首页 > 过刊浏览>2024年第6期 >769-773. DOI:10.3969/j.issn.2095-1264.2024.06.18

纳武利尤单抗致中毒性表皮坏死松解症1例
DOI:
                        10.3969/j.issn.2095-1264.2024.06.18
                    
作者:
                        
                        
                    
作者单位:南通大学附属医院 药学部，江苏 南通，226001
作者简介:顾融融，女，硕士，主管药师，研究方向为临床药学。
通讯作者:殷晓芹，女，硕士，主任药师，研究方向为临床药学。
中图分类号:R734.2;R979.5
基金项目:

A case report of nivolumab-associated toxic epidermal necrolysis

Author:

Affiliation:

Department of Pharmacy, the Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu, China

Fund Project:

摘要

图/表

访问统计

参考文献

相似文献

引证文献

资源附件

文章评论

摘要:

本文报道了１例肺鳞癌患者在使用纳武利尤单抗联合含铂化疗方案后出现中毒性表皮坏死松解症的病例。文章详细描述了该患者的症状，疾病的发生发展、治疗及转归过程，分析其病例特征，并对国内外关于纳武利尤单抗致中毒性表皮坏死松解症的相关报道进行讨论。

Abstract:

Here reported was a case of toxic epidermal necrolysis in a patient with lung squamous cell carcinoma after treatment with nivolumab combined with platinum-based chemotherapy. In this article, we discribed in detail the symptoms, disease development, treatment and outcome of the patient, analyzed the characteristics of the case, and discussed as well the relevant reports on toxic epidermal necrolysis caused by nivolumab at home and abroad.